IP Library Assignment 056120/0084
Patent Assignment
Reel/Frame 056120/0084

Assignment of Assignor's Interest

Recorded: 2021-05-03 Pages: 7
Assignors
XIONG, XIAOFENG
Executed: 2018-06-12
ODINK, DEBRA
Executed: 2018-06-12
SMITH, CHRISTINE M.N.
Executed: 2018-06-12
CRAIG, COLLEEN M.
Executed: 2018-06-18
Assignee
EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BOULEVARD, PALO ALTO, CALIFORNIA, 94306
Covered Properties (2)
Buffered Formulations Of Exendin (9-39)
Application: 16/461,329 →
Publication: US 2020/0069802
Methods of Using Buffered Formulations of Exendin (9-39)
Application: 17/306,782 →
Publication: US 2021/0315995
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 19, 2021
From: MCLAUGHLIN, TRACEY L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 055657/0319 →
Assignment of Assignor's Interest May 3, 2021
From: MCLAUGHLIN, TRACEY L.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 056120/0107 →
Security Interest Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest Aug 14, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068283/0933 →
Assignment of Assignor's Interest Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →